Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer
    Meeting Abstract

    Korsen, J.; Kalidindi, T.; Khitrov, S.; Khuram, H.; Piorier, J.; Rudin, C.; Chen, Y.; Pillarsetty, N. V. K.; Lewis, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • GT3-Nano based radioprotector drug promotes rapid recovery from (153)Sm-EDTMP induced myelotoxcity
    Meeting Abstract

    Lee, S. G.; Kalidindi, T. M.; Punzalan, B.; Pillarsetty, N.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Multicycle pretargeted radioimmunotherapy using 177(Lu) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; Punzalan, B.; Veach, D.; Xu, H.; Guo, H. F.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted radioimmunotherapy using 225(Ac) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; McDevitt, M.; Xu, H.; Guo, H. F.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted alpha radioimmunotherapy (DOTA-PRIT) for HER2-expressing human gastric cancer: A theranostic approach using 111(In)/225(Ac)-radiohapten
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • (225)Ac-alpha pretargeted radioimmunotherapy (DOTA-PRIT) of human colorectal cancer: Achieving 100% complete responses with single-cycle targeting of 2 distinct antigens, HER2 and GPA33
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib, obinutuzumab, and venetoclax
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Carter, J.; Dogan, A.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; Abramson, J. S.; Batlevi, C. L.; Joffe, E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Developing a breast cancer tissue biobank in low and middle income countries (LMICs): A research program-based approach for improving molecular profiling
    Meeting Abstract

    Sharma, A.; Odujoko, O. O.; Alatise, O. I.; Edelweiss, M.; Ntiamoah, P.; Ogunleye, G. S.; Kingham, T. P.; Iyengar, N. M.; African Research Group for Oncology (ARGO)
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Genomic drivers and clinical outcomes
    Meeting Abstract

    Sassine, D.; Straubhar, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Kyi, C.; Leitao, M. M.; Mueller, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of antibiotics (ATB) on the recurrence of resected colorectal cancer (CRC): Results of EVADER-1 a nation-wide pharmacoepidemiologic study
    Meeting Abstract

    Rousseau, B.; Hilmi, M.; Khati, I.; Turpin, A.; Andremont, A.; Burdet, C.; Grall, N.; Vidal, J.; Bousquet, P. J.; Le Bihan, C.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save